Skip to main content

MARSHALL WACE, LLP

Position in BDTX — Black Diamond Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in BDTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,781,246
-$916,267 QoQ
Shares Held
836,266
-24.7% QoQ
Ownership
1.46%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BDTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,756,303,735 across 280 Biotechnology names. BDTX ranks #161 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BDTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,781,246 836,266
2025-12-31 $2,697,513 1,110,088
2025-09-30 $4,923,997 1,299,208
2025-06-30 $1,829,929 737,875
2024-09-30 $422,672 97,166
2024-06-30 $440,542 94,537
2023-12-31 $64,416 22,924
2021-03-31 $3,402,028 140,232
2020-12-31 $1,380,746 43,081
2020-06-30 $337,575 8,007
2020-03-31 $718,310 28,790